Будь ласка, використовуйте цей ідентифікатор, щоб цитувати або посилатися на цей матеріал: http://ir.librarynmu.com/handle/123456789/17413
Повний запис метаданих
Поле DCЗначенняМова
dc.contributor.authorPushkarova, Y.-
dc.contributor.authorZaitseva, G.-
dc.contributor.authorBouaalam, K.-
dc.date.accessioned2026-02-06T11:36:08Z-
dc.date.available2026-02-06T11:36:08Z-
dc.date.issued2025-
dc.identifier.issndoi: https://doi.org/10.5599/admet.2945-
dc.identifier.urihttp://ir.librarynmu.com/handle/123456789/17413-
dc.description.abstractBackground and purpose: Prediction of metabolism and solubility of tablet-form drugs is essential in pharmaceutical development, impacting drug efficacy, safety and formulation strategies. This study aimed to develop predictive models for classifying drugs according to metabolism and solubility within the Biopharmaceutical Drug Disposition Classification System. Experimental approach: A dataset of 220 tabletform drugs characterized by eleven molecular descriptors was analysed. The Kruskal–Wallis test identified relevant descriptors for metabolism (extensive vs. poor) and solubility (high vs. low) classifications. Probabilistic Neural Networks were employed for predictive modelling, with model parameters optimized to enhance accuracy. Key results: Six molecular descriptors (hydrogen bond acidity, logarithm of the partition coefficient, distribution coefficient, hydrogen bond acceptor count, molecular weight and polar surface area) predicted metabolism class with 97 % accuracy. For solubility classification, five descriptors (dipolarity/polarizability, logarithm of the partition coefficient, distribution coefficient, hydrogen bond donor count and molecular weight) achieved 88 % accuracy. Removal of key descriptors significantly reduced model performance, confirming their importance. Conclusion: The developed models demonstrate robust predictive capability for drug metabolism and solubility classes as defined by the Biopharmaceutical Drug Disposition Classification System, supporting early-stage drug screening based solely on molecular structure. The lower accuracy observed for solubility prediction reflects its complex and multifactorial nature, highlighting the need for further refinement of molecular descriptors. These findings advance the field by providing effective computational tools to predict key biopharmaceutical properties, potentially accelerating the drug development process.uk_UA
dc.language.isoenuk_UA
dc.publisherADMET & DMPKuk_UA
dc.subjectMolecular descriptors; probabilistic neural network; chemometrics; drug classification.uk_UA
dc.titlePrediction of metabolism and solubility of tablet-form drugs according to the biopharmaceutical drug disposition classification systemuk_UA
dc.typeArticleuk_UA
Розташовується у зібраннях:Наукові публікації кафедри аналітичної, фізичної та колоїдної хімії



Усі матеріали в архіві електронних ресурсів захищені авторським правом, всі права збережені.